Abstract
Modern bioprocess development includes extensive screening tasks, but many tools tackling the resulting combinatorial explosion do not provide production scale relevant conditions. Thus, novel technologies are needed for scalable data acquisition via incorporation of miniaturization, automation and digitalization. The Microbial Bioprocess Lab–a Helmholtz Innovation Lab strives at designing such disruptive technologies and to catalyze their translation from science into industrial application.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Biospektrum : Zeitschrift der Gesellschaft fur Biologishe Chemie (GBCH) und der Vereinigung fur Allgemeine und Angewandte Mikrobiologie (VAAM)
Paper Title
Journal
Date
